Neural Network and Physiological Parameters Based Control of Artificial Pancreas for Improved Patient Safety

Acyber-physical system (CPS) establishes a close interaction between system's computational core and the control of physical process. In case of Diabetes, failure in endogenous insulin production requires exogenous infusion of required drug amount. We have proposed an architecture for artificial pancreas and checked its validity in simulations. The aim is to control blood glucose level (BGL) of a patient suffering from diabetes and to prevent the harmful state of Hypoglycemia. For this, vital signs monitoring is introduced through which hypoglycemic condition can be efficiently detected and avoided. Electrocardiogram, Heart beat rate, Electroencephalography and skin resistance are known to depict an irregularity in blood glucose. Upon detection, a specified amount of Glucagon is infused into patient's body. The system consists of an insulin infusion and glucagon pump, through which insulin/glucagon is entered into the patient's body subcutaneously, based on the current BGL. A neural network predictive controller is designed to keep the glucose level inside the desired 'safe range'. The simulations have shown that patient safety can be improved through this strategy.

[1]  Insup Lee,et al.  Medical Cyber Physical Systems , 2010, Design Automation Conference.

[2]  Jiming Chen,et al.  Continuous Drug Infusion for Diabetes Therapy: A Closed-Loop Control System Design , 2008, EURASIP J. Wirel. Commun. Netw..

[3]  J. Leahy,et al.  Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .

[4]  P. Cryer,et al.  Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes* , 2002, Diabetologia.

[5]  F. Chee,et al.  Simulation study on automatic blood glucose control , 2001, The Seventh Australian and New Zealand Intelligent Information Systems Conference, 2001.

[6]  S. Kahn,et al.  Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds. , 2000, Diabetes care.

[7]  Andrey V. Savkin,et al.  Optimal H∞ insulin injection control for blood glucose regulation in diabetic patients , 2005, IEEE Trans. Biomed. Eng..

[8]  J. Zeitlhofer,et al.  Monitoring set-up for selection of parameters for detection of hypoglycaemia in diabetic patients , 2007, Medical and Biological Engineering and Computing.

[9]  B. Bequette A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[10]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[11]  H. Nguyen,et al.  Real-time detection of nocturnal hypoglycemic episodes using a novel non-invasive hypoglycemia monitor , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[12]  A. El-Jabali Neural network modeling and control of type 1 diabetes mellitus , 2005, Bioprocess and biosystems engineering.

[13]  R. Hintsche,et al.  Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin , 2006, IEEE Transactions on Information Technology in Biomedicine.

[14]  J. B. Collip,et al.  Pancreatic extracts in the treatment of diabetes mellitus: preliminary report. 1922. , 1991, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[15]  Roman Hovorka,et al.  Closing the loop: the adicol experience. , 2004, Diabetes technology & therapeutics.

[16]  R. Bellazzi,et al.  The subcutaneous route to insulin-dependent diabetes therapy. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[17]  Jefferson Luiz Brum Marques,et al.  Altered ventricular repolarization during hypoglycaemia in patients with diabetes , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[18]  David C Klonoff,et al.  The Artificial Pancreas: How Sweet Engineering Will Solve Bitter Problems , 2007, Journal of diabetes science and technology.

[19]  Hiok Chai Quek,et al.  A personalized approach to insulin regulation using brain-inspired neural sematic memory in diabetic glucose control , 2007, 2007 IEEE Congress on Evolutionary Computation.

[20]  E Renard,et al.  Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. , 2006, Diabetes & metabolism.

[21]  S R Heller,et al.  Physiological disturbances in hypoglycaemia: effect on subjective awareness. , 1991, Clinical science.

[22]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[23]  Enrique J. Gómez,et al.  The INCA System: A Further Step Towards a Telemedical Artificial Pancreas , 2008, IEEE Transactions on Information Technology in Biomedicine.

[24]  Francis J. Doyle,et al.  Run-to-run control of blood glucose concentrations for people with type 1 diabetes mellitus , 2006, IEEE Transactions on Biomedical Engineering.

[25]  Roman Hovorka,et al.  The future of continuous glucose monitoring: closed loop. , 2008, Current diabetes reviews.

[26]  Efstratios N. Pistikopoulos,et al.  Model-based blood glucose control for type 1 diabetes via parametric programming , 2006, IEEE Transactions on Biomedical Engineering.

[27]  W. Kenneth Ward,et al.  A Review of Closed-Loop Algorithms for Glycemic Control in the Treatment of Type 1 Diabetes , 2009, Algorithms.

[28]  Nicholas A Peppas,et al.  The future of open‐ and closed‐loop insulin delivery systems , 2008, The Journal of pharmacy and pharmacology.

[29]  W. Kenneth Ward,et al.  Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes , 2010, Diabetes Care.

[30]  Heikki V Huikuri,et al.  Effects of sustained insulin-induced hypoglycemia on cardiovascular autonomic regulation in type 1 diabetes. , 2005, Diabetes.

[31]  R. Hovorka Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[32]  R S Parker,et al.  The intravenous route to blood glucose control. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.